RNA-based approaches, like mRNA vaccines and antisense oligonucleotides (ASOs) have recently emerged as promising solutions.
There is a growing need for targeted therapeutics for diseases that result from imbalances in protein production. RNA-based approaches, like mRNA vaccines and antisense oligonucleotides (ASOs) have recently emerged as promising solutions. However, a key challenge still remains in precisely modulating protein expression through these approaches.